Nateghpour Mehdi, Farivar Leila, Souri Effat, Hajjaran Homa, Mohebali Mehdi, Motevalli Haghi Afsane
Department of Medical Parasitology and Mycology , School of Public Health , Tehran University of Medical Sciences ( TUMS ), Tehran , Iran .
Iran J Pharm Res. 2012 Spring;11(2):583-8.
Malaria is one of the worldwide parasitic diseases which threaten the life of hundreds of millions of people at the malarious areas each year. The emergence of chloroquine-resistant strains of Plasmodium falciparum in most of the malarious areas has encountered the relevant countries with some difficulties about treating the acute cases of the disease particulary if the monotherapy regimen has been used. Because of many advantages for the combination therapy, the effectiveness of chloroquine (CQ) and Otostegia persica (OP), a medicinal plant in combination form, was tested against the chloroquine-sensitive and chloroquine-resistant strains of Plasmodium berghei in sourian mouse using in-vivo adapted fixed ratios method in this study. At the first step, ED50s (50% effective dose) of chloroquine and O. persica against both CQ-sensitive and CQ-resistant strains of P. berghei were calculated using in-vivo test in the mice. Ratios of 0, 10, 30, 50, 70, 90 and100% from each ED50 were prepared and contrarily combined together to make the following fixed ratios of 0/100, 10/90, 30/70, 50/50, 70/30, 90/10, and 100/0 of CQ/OP and the parasites were exposed to the combined ratios. Determination of ED50s showed 1.1 mg/Kg and 2.4 mg/Kg of mouse body weight for chloroquine in CQ-sensitive and CQ-resistant strains respectively and 450 mg/Kg for O. persica in both strains. The results also showed that the combinations of "50% CQ + 50% OP", "30% CQ + 70% O.P" and "70% CQ + 30% OP" were more effective than other combinations against CQ-sensitive strain. The fixed ratio combinations of chloroquine and O. persica showed an additive in CQ-resistant strain. Toxicity consideration showed no toxic effect of the combinations on the mice. Otostegia persica potentiated the effectiveness of chloroquine against the chloroquine-sensitive strain of P. berghei but not on chloroquine-resistant P. berghei. Moreover, the greatly modified fixed ratios method in this study can be considered as useful methods for in-vivo combination tests in murine malaria parasites.
疟疾是一种全球性寄生虫病,每年威胁着疟疾流行地区数亿人的生命。大多数疟疾流行地区出现的恶性疟原虫氯喹抗性菌株给相关国家治疗该疾病的急性病例带来了一些困难,特别是在使用单一疗法时。由于联合疗法具有许多优点,本研究采用体内适应性固定比例法,测试了氯喹(CQ)与药用植物波斯刺蕊草(OP)联合使用对叙利亚小鼠体内伯氏疟原虫氯喹敏感株和氯喹抗性株的有效性。第一步,通过小鼠体内试验计算氯喹和波斯刺蕊草对伯氏疟原虫氯喹敏感株和氯喹抗性株的半数有效剂量(ED50)。分别从每种ED50中取0、10、30、50、70、90和100%的比例,反向组合得到以下氯喹/波斯刺蕊草的固定比例:0/100、10/90、30/70、50/50、70/30、90/10和100/0,并将寄生虫暴露于这些组合比例下。ED50的测定结果显示,氯喹对氯喹敏感株和氯喹抗性株的小鼠体重半数有效剂量分别为1.1mg/Kg和2.4mg/Kg,波斯刺蕊草对两种菌株的半数有效剂量均为450mg/Kg。结果还表明,“50%氯喹+50%波斯刺蕊草”、“30%氯喹+70%波斯刺蕊草”和“70%氯喹+30%波斯刺蕊草”的组合对氯喹敏感株的效果优于其他组合。氯喹和波斯刺蕊草的固定比例组合在氯喹抗性株中显示出相加作用。毒性考量显示这些组合对小鼠没有毒性作用。波斯刺蕊草增强了氯喹对伯氏疟原虫氯喹敏感株的有效性,但对氯喹抗性伯氏疟原虫无效。此外,本研究中大幅改进的固定比例法可被视为用于鼠疟原虫体内联合试验的有用方法。